Corrigendum to "A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" [Eur J Canc 131 (2020) 68–75]. (February 2021) - Lala, Mallika; Li, Tommy Ruosi; de Alwis, Dinesh P.; Sinha, Vikram; Mayawala, Kapil; Li, Mengyao; Yamamoto, Noboru; Siu, Lillian L.; Chartash, Elliot; Aboshady, Hesham; Jain, Lokesh